(BQ) Part 1 book "Preventing hospital infections - Real-world problems, realistic solutions" presents the following contents: A new strategy to combat hospital infections, committing to an infection prevention initiative, types of interventions, building the team.
(BQ) Part 1 book "Preventing hospital infections - Real-world problems, realistic solutions" presents the following contents: The importance of leadership and followership, common problems, realistic solutions, toward sustainability, the collaborative approach to preventing infection, the collaborative approach to preventing infection,...
Intravascular catheters are an integral part of the daily practice of
medicine in the intensive care unit. As such, management of these catheters
poses significant challenges to the practitioner. Vascular access is necessary
in the intensive care setting, yet the devices themselves put patients at
significant risk for infection. As hospital infection rates are increasingly used
as a surrogate marker for measuring patient safety and quality healthcare,
preventing catheter-related infection takes on added import...
Patients in whom diphtheria is suspected should be hospitalized in respiratory isolation rooms, with close monitoring of cardiac and respiratory function. A cardiac workup is recommended to assess the possibility of myocarditis. In patients with extensive pseudomembranes, consultation with an anesthesiologist or an ear, nose, and throat specialist is recommended because of the possibility that tracheostomy or intubation will be required. In some settings, pseudomembranes can be removed surgically.
Urinary Tract Infections Urinary tract infections (UTIs) account for as many as 40–45% of nosocomial infections; up to 3% of bacteriuric patients develop bacteremia. Although UTIs contribute only 10–15% to prolongation of hospital stay and to extra costs, these infections are important reservoirs and sources for spread of antibiotic-resistant bacteria in hospitals. Almost all nosocomial UTIs are associated with preceding instrumentation or indwelling bladder catheters, which create a 3–10% risk of infection each day.
Middle-Period Infections Because of continuing immunosuppression, kidney transplant recipients are predisposed to lung infections characteristic of those in patients with T cell deficiency (i.e., infections with intracellular bacteria, mycobacteria, nocardiae, fungi, viruses, and parasites). The high mortality rates associated with Legionella pneumophila infection (Chap. 141) led to the closing of renal transplant units in hospitals with endemic legionellosis.
For hospitalized patients, the following two parenteral regimens have given nearly identical results in a multicenter randomized trial:
Doxycycline (100 mg twice daily, given IV or PO) plus
cefotetan (2.0 g IV every 12 h) or cefoxitin (2.0 g IV every 6 h). Administration of these drugs should be continued by the IV route for at least 48 h after the patient's condition improves and then followed with oral doxycycline (100 mg twice daily) to complete 14 days of therapy.
Clindamycin (900 mg IV every 8 h) plus gentamicin (2.0
mg/kg IV or IM, followed by 1.
Nhiễm trùng bệnh viện : (Hospital infection hay Nosocomial infection ) : nhiễm trùng mắc phải trong thời gian nằm bệnh viện
Xảy ra trong 48-72 giờ sau khi nhập viện và trong vòng 10 ngày sau khi bệnh nhân xuất viện
PHI has often financed the delivery of larger treatment volumes by offering higher payments to
providers. Financial incentives linked to payment mechanisms exert a direct impact upon doctors’
productivity.32 This has contributed to a growth in the volumes of private hospital treatments in several
countries where doctors have both public and private sector engagements, as in Australia and Ireland
(Colombo and Tapay, 2003 and 2004b).
Chapter 125. Health Care– Associated Infections (Part 1)
Harrison's Internal Medicine Chapter 125. Health Care–Associated Infections
Health Care–Associated Infections: Introduction
The costs of hospital-acquired (nosocomial) and other health care– associated infections are great. It is estimated that these infections affect 2 million patients, cost $4.5 billion, and contribute to 88,000 deaths in U.S. hospitals annually.
Chapter 125. Health Care– Associated Infections (Part 2)
Organization, Responsibilities, and Increasing Scrutiny of InfectionControl Programs
The standards of the Joint Commission on Accreditation of Healthcare Organizations require all accredited hospitals to have an active program for surveillance, prevention, and control of nosocomial infections. Education of physicians in infection control and health care epidemiology is required in infectious disease fellowship programs and is available by online courses.
DIABETIC FOOT DISORDERS
VOLUME 45, NUMBER 5, SEPTEMBER/OCTOBER 2006
be present. Hospitalization is required to treat the infection as well as systemic sequelae. Patients with poor vascular status and ischemia have an increased potential for amputation and require prompt consultation for potential revascularization (30, 77, 200). In 2004, the Infectious Disease Society of America (IDSA) developed new guidelines for the diagnosis and treatment of diabetic foot infections (123).
This products classification system facilitates rapid research about the needed medical
devices. It is also a guarantee of maintaining coherence in the whole list and obtaining a clear
overview of what is needed to set up a reproductive health service.
The list of products is specified by two levels of care: the first level of MNH care and the
Stroke is a vascular disease for which mortality and morbidity are relatively
well-documented because most stroke victims are admitted to hospitals. Trends in
stroke mortality, incidence, and prevalence are somewhat similar to those for other
cardiovascular conditions. Stroke mortality has been decreasing since the 1960s,
but without a consistent decrease in stroke incidence. Stroke incidence has even
been reported to have been higher in the 1980s than during the 1970s, and there
was no sustained decline in incidence during the 1990s....
An estimated 41,000 central line-associated bloodstream infections (CLABSI) occur in U.S. hospitals each year.1 These infections are usually serious infections typically causing a prolongation of hospital stay and increased cost and risk of mortality.
CLABSI can be prevented through proper insertion techniques and management of the central line. These techniques are addressed in the CDC’s Healthcare Infection Control Practices Advisory Committee (CDC/HIPAC) Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011.
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care cung cấp cho các bạn kiến thức về ngành y đề tài: Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study...
The costs of hospital-acquired (nosocomial) and other health care– associated infections are great. It is estimated that these infections affect 2 million patients, cost $4.5 billion, and contribute to 88,000 deaths in U.S. hospitals annually. Efforts to lower infection risks have been challenged by the growing numbers of immunocompromised patients, antibiotic-resistant bacteria, fungal and viral superinfections, and invasive devices and procedures.
Hospitals, by their very nature, are dangerous places. Sick and infected patients
are clustered together in one institution, often in close proximity to those who are
immunosuppressed due to recent surgery, chemotherapy or transplantation. Contact
between these various patient groups is easily achieved via the hands of healthcare
workers (HCWs), use of shared equipment or the hospital’s air handling system.
In sub-Saharan Africa, as high as 2/3 of tuberculosis patients are HIV/AIDS co-infected and
tuberculosis is the most common cause of death among HIV/AIDS patients worldwide. Tuberculosis and HIV
co-infections are associated with special diagnostic and therapeutic challenges and constitute an immense burden
on healthcare systems of heavily infected countries like Ethiopia. The aim of the study was to determine the
prevalence of pulmonary tuberculosis and their immunologic profiles among HIV positive patients.